Contributors



Monica Smith

Latest:

Testing for Recurrence

Early-stage colorectal cancer patients may benefit from a new test that predicts their risk of recurrence.


National Community Oncology Dispensing Association, Inc.

Latest:

NCODA Welcomes Three New Executive Council Members

The National Community Oncology Dispensing Association, Inc. (NCODA) is pleased to announce the addition of three new members to the Executive Council.


Bradley McGregor, M.D.

Latest:

Combination Therapies Open New Doors in Renal Cell Carcinoma Studies

Utilizing the data of the CheckMate 9ER trial, researchers believe that combination therapies in the treatment of patients with renal cell carcinoma are the future of the landscape.


Rona Cherry

Latest:

My Secret Life With Ovarian Cancer

“For so long ovarian cancer has been a secret part of my life. That’s over now.”


Elaine Schattner, MD

Latest:

Unlocking the Mystery of Cancer Stem Cells

Scientists research whether cancer stem cells are the key to eradicating the disease.


Caroline Seymour

Latest:

Survival Benefits with Keytruda and Padcev in Advanced Urothelial Cancer

Patients with previously untreated locally advanced or metastatic urothelial carcinoma experienced favorable progression-free survival, overall survival and objective response rates when treated with Padcev and Keytruda versus chemotherapy.


Tom Weatherall

Latest:

Granting Wishes for Pediatric Patients

All the wishes granted at Make-A-Wish New Jersey are special, from meet and greets with A-list celebrities, to smaller wishes that are just as meaningful.


Karl Kilgore, PhD

Latest:

Real-World Data Shows Promise for Patients on CAR-T Therapy

Real-world data shows that CAR-T therapy can lower costs for patients with pre-existing comorbidities outside of the clinical setting.


Mark Socinski, M.D.

Latest:

Advanced Lung Cancer Outlook Is Better Than Before

Thanks to better understanding of cancer biology, the outlook for advanced lung cancer is better than it has ever been.



Rebekah Harrison

Latest:

Sarcoma Foundation of America Uses a Multi-Faceted Approach to Fighting the Disease

When it comes to fighting sarcoma, the Sarcoma Foundation of America does not stop at fundraising.


Rebecca Arend, M.D.

Latest:

Expert Discusses Exciting Advances in Ovarian Cancer

Rebecca Arend, M.D., gynecologic oncologist at University of Alabama at Birmingham Hospital, discusses the rapidly changing field of ovarian cancer.


Greg Simon

Latest:

Greg Simon on the Biden Cancer Initiative

Greg Simon, CEO of the Biden Cancer Initiative, discusses the transition from the Cancer Moonshot Initiative to the Biden Cancer Initiative.


Terry Arnold

Latest:

Birthdays Mark Milestones

Inflammatory breast cancer survivor, Terry Arnold, shares her story of diagnosis and survivorship.


NATE BILINSKI

Latest:

How One Person Beat Cancer by Participating in a Clinical Trial

After being diagnosed with glioblastoma, experimental immunotherapy saved his life.


William Tseng, MD

Latest:

You Are Not Alone: The Sarcoma Alliance as a Patient Advocate

A nonprofit organization aims to connect patients, caregivers and loved ones affected by sarcoma while educating those about the rare cancer.


Stephen Labay

Latest:

Superman, Sort Of

Twenty-year-old men think they are invincible. They wake up each morning thinking that nothing can stop them and that is one of the best feelings in the world.


Margaret Patterson

Latest:

She Gives Me Courage

MY FAVORITE NURSE, Susanne, is a model in courage and persistence.


NCODA

Latest:

Barry D. Brooks, M.D., Joins NCODA Executive Council

The National Community Oncology Dispensing Association, Inc. (NCODA) is pleased to announce the addition of Barry D. Brooks, M.D. to their Executive Council. Dr. Brooks joined the Council in April.


Elliott Winton, M.D.

Latest:

Elliott Winton on the Changing Landscape of MPN Treatment

Elliott Winton, M.D., researcher, physician and 2016 MPN Hero, discusses some of the drastic changes that happened over the past decade or so in the world of MPNs.


The American Hospice Foundation

Latest:

Web Exclusive: Understanding Hospice

Hospice care or palliative care: What's the right care for me?


Lynne Lederman, PhD

Latest:

Immunotherapy Combination Demonstrates Benefit in Small, Early Trial of Melanoma

A small, early trial demonstrated that a combination of Imlygic and Keytruda can have clinical benefit for patients with advanced melanoma.


Kurt Ullman

Latest:

Taking a Detour

After ostomies, patients must adjust to their new bodies, but can live full, active lives.


Michael E. Reid

Latest:

Acknowledging Loss

Prostate cancer survivor says acknowledging the loss of his sexuality is the first step toward getting it back.


Katie Thiede, Chief Executive Officer at Bright Pink

Latest:

Opinion: Breast Cancer's Pink Isn't Black and White

How has the most successful cancer awareness movement become so polarizing?


Marcy Worthington

Latest:

Knowledge Is Key in Patient Advocacy

Understanding the disease and treatments are key aspects of being a patient advocate, explained MPN Hero Marcy Worthington.


Lisa Machado

Latest:

Power to the Patients

Real-time access to test results and doctors’ reports is putting control over health into the hands of patients.



Dr. Arash Rezazadeh Kalebasty

Latest:

Jevtana's Toxicity Profile Makes It a Good Option in Metastatic Prostate Cancer

When other therapies have failed, patients with metastatic prostate cancer who were treated with Jevtana (cabazitaxel) in the third-line setting experienced a toxicity profile similar to that of androgen-targeted therapies, making the chemotherapy agent a valid choice for some patients, according to results from the CARD trial.